Trivalent influenza vaccine and febrile adverse events in Australia, 2010: Clinical features and potential mechanisms

This publication has 16 references indexed in Scilit:

• Lessons from the first year of the WAIVE study investigating the protective effect of influenza vaccine against laboratory‐confirmed influenza in hospitalised children aged 6–59 months
  Influenza and Other Respiratory Viruses, 2010
• Detection of respiratory viruses and the associated chemokine responses in serious acute respiratory illness
  Thorax, 2010
• Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6–23 months of age
  Vaccine, 2009
• Safety of Trivalent Inactivated Influenza Vaccine in Children 6 to 23 Months Old
  JAMA, 2006
• Adverse Events After Inactivated Influenza Vaccination Among Children Less Than 2 Years of Age: Analysis of Reports From the Vaccine Adverse Event Reporting System, 1990–2003
  Pediatrics, 2005
• Safety of the Trivalent Inactivated Influenza Vaccine Among Children
  Archives of Pediatrics & Adolescent Medicine, 2004
• Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation
  Vaccine, 2003
• Possible contribution of interferon-α to febrile seizures in influenza
  Pediatric Neurology, 2002
• Differential Mononuclear Leukocyte Attracting Chemokine Production after Stimulation with Active and Inactivated Influenza A Virus
  Cellular Immunology, 1998
• Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense.
  Journal of Clinical Investigation, 1998